XML 17 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statement of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net earnings $ 823 $ 709
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Net gain on investments and other 2 (6)
Depreciation and amortization 339 255
Change in estimated acquisition earnout payables 17 15
Amortization of deferred compensation and restricted stock 33 28
Stock-based and other noncash compensation expense 17 14
Payments on acquisition earnouts in excess of original estimates (45) (10)
Provision for deferred income taxes 97 56
Effect of changes in foreign exchange rates (4) 24
Net change in accounts receivable, net (869) (658)
Net change in deferred revenue 87 78
Net change in other current assets 84 18
Net change in accrued compensation and other accrued liabilities 411 416
Net change in income taxes payable 52 27
Net change in other noncurrent assets and liabilities (87) (94)
Net cash provided by operating activities 957 872
Cash flows from investing activities:    
Capital expenditures (36) (28)
Cash paid for acquisitions, net of cash and restricted cash acquired (289) (332)
Net proceeds from sales of operations/books of business 4 2
Net funding of investment transactions 1 0
Net funding of premium finance loans 82 83
Net cash used by investing activities (238) (275)
Cash flows from financing activities:    
Payments on acquisition earnouts (115) (11)
Proceeds from issuance of common stock 55 1,335
Repurchases of common stock (310) 0
Dividends paid (180) (166)
Net change in fiduciary assets and liabilities (68) 21
Net borrowings on premium financing debt facility (78) (75)
Borrowings on line of credit facility 1,975 0
Repayments on line of credit facility (1,690) 0
Net borrowings of corporate related long-term debt (314) 1
Debt acquisition costs 2 2
Net cash (used) provided by financing activities (723) 1,107
Effect of changes in foreign exchange rates on cash, cash equivalents, restricted cash and fiduciary cash (52) 67
Net (decrease) increase in cash, cash equivalents, restricted cash and fiduciary cash (56) 1,771
Cash, cash equivalents, restricted cash and fiduciary cash at beginning of period 8,538 20,468
Cash, cash equivalents, restricted cash and fiduciary cash at end of period $ 8,482 $ 22,239